Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential“ or “concomitant“ treatment to eradicate H. pylori infection

By Gisbert Javier P.  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 6, 2013-06 ,pp. : 652-656

Informa Healthcare

Access to resources Recommend Favorite

Seven-Day Triple Therapy with Omeprazole, Amoxycillin and Clarithromycin for Helicobacter pylori Infection in Haemodialysis Patients

By Tsukada K.   Miyazaki T.   Katoh H.   Masuda N.   Ojima H.   Fukai Y.   Nakajima M.   Manda R.   Fukuchi M.   Kuwano H.   Tsukada O.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 11, 2002-11 ,pp. : 1265-1268

Informa Healthcare

Access to resources Recommend Favorite

Clarithromycin-based Triple Therapy for Non-Resistant Helicobacter pylori infection. How Long Should It Be Given?

By Ogura K.   Yoshida H.   Maeda S.   Yamaji Y.   Kawabe T.   Okamoto M.   Shiratori Y.   Omata M.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 6, 2001-06 ,pp. : 584-588

Informa Healthcare

Access to resources Recommend Favorite

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

By Gisbert J.   Perez-Aisa A.   Rodrigo L.   Molina-Infante J.   Modolell I.   Bermejo F.   Castro-Fernández M.   Antón R.   Sacristán B.   Cosme A.   Barrio J.   Harb Y.   Gonzalez-Barcenas M.   Fernandez-Bermejo M.   Algaba A.   Marín A.   McNicholl A.  

Digestive Diseases and Sciences, Vol. 59, Iss. 2, 2014-02 ,pp. : 383-389

Springer Publishing Company

Access to resources Recommend Favorite

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

By Xiao Shu-Ping   Gu Min   Zhang Guo-Xin  

Scandinavian Journal of Gastroenterology, Vol. 49, Iss. 5, 2014-05 ,pp. : 528-538

Informa Healthcare

Access to resources Recommend Favorite